Identification, Isolation, and Reprogramming Alveolar Epithelial Progenitor Cells
Identification, Isolation, and Reprogramming Alveolar Epithelial Progenitor Cells
批准号:
7676645
负责人:
Harold A Chapman
金额:
$3.86万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-05-31
关键词:
Acute Lung InjuryAdultAlveolarAlveolar CellAppearanceBiological AssayBiologyBloodBlood VesselsBreastCardiacCellsCellular biologyCicatrixClinicalComplexCuesDevelopmentDistalElementsEmbryoEpithelialEpithelial CellsEpitheliumExtracellular MatrixFunctional disorderGene ExpressionInjuryLungMesenchymeMethodsMusPatternPhenotypeProcessProgram DevelopmentPublishingPulmonary EmphysemaPulmonary FibrosisReagentResearchStem cellsStructureTechnologyTherapeuticTimeTissuesTransplantationType II Epithelial Receptor CellWorkalveolar epitheliumhuman diseasein vivointerestlung developmentprogenitorprogramsrepaired
中文摘要
描述(申请人提供):肺泡上皮与许多重要的人类疾病密切相关,包括肺气肿、急性肺损伤和肺纤维化。在每种情况下,产生新的肺泡上皮的能力都将具有巨大的潜在治疗价值,但这样的项目仍然超出了当前技术的能力范围。尽管在鉴定和操作心脏和血祖细胞方面已经取得了很大进展,但肺内祖细胞生物学的进展受到了与肺研究相关的几个重大挑战的影响,包括肺的复杂解剖结构、固有的周转速度慢以及缺乏评估推测的祖细胞发育潜力的移植试验。为了突破目前对肺发育和修复的研究的限制,这一应用将集中在远端呼吸道和肺泡上皮的生物学上,将三个在上皮祖细胞生物学方面具有不同专业知识但兴趣重叠的研究小组聚集在一起。第一个小组由Ross Metzger领导,他最近发表了对小鼠胚胎肺形成期间呼吸道分支模式的详细描述。这项工作为定位和确定肺发育过程中肺泡祖细胞出现的时间提供了一个框架,并提出了关于近端和远端上皮分化的重要新问题。第二个小组由Zena Werb领导,对肺发育问题带来了广泛的研究乳房发育和重塑的记录,特别关注间充质对上皮祖细胞(Re)编程的影响,以及可视化这一过程的方法的发展。第三个小组由PI和他的同事领导,正在创造谱系追踪试剂,以促进对肺泡上皮祖细胞的识别和分离,允许对祖细胞分析进行明确的解释,并提供一种方法来探索环境线索,特别是细胞外基质的能力,以指导成年II型细胞对多种表型的编程。该项目的主要目标是开发分离和鉴定胚胎肺泡细胞前体细胞的方法,比较这些细胞与成人II型细胞的基因表达和发育潜力,阐明具有祖细胞潜力的成人II型细胞重新编程的线索,并建立体内移植试验来验证和筛选前体细胞与血管分子结合和形成肺泡组织的能力。
英文摘要
DESCRIPTION (provided by applicant): The pulmonary alveolar epithelium is prominently involved in a number of important human diseases, including emphysema, acute lung injury, and pulmonary fibrosis. In each of these conditions the capacity to generate new alveolar epithelium would be of great potential therapeutic value, but such a project remains beyond the reach of current technology. Although much progress has been made in identifying and manipulating cardiac and blood progenitor cells, progress on progenitor cell biology in the lung has been slowed by several significant challenges associated with studying the lung, including its complex anatomical structure, slow intrinsic rate of turnover, and the absence of a transplantation assay to assess the developmental potential of putative progenitor cells. In order to move beyond the limitations of current research into lung development and repair, this application will focus on the biology of the distal airway and alveolar epithelium, bringing together three investigative groups with different expertise but overlapping interests in epithelial progenitor cell biology. The first group is led by Ross Metzger, who generated the recently published detailed description of the pattern of airway branching during embryonic mouse lung formation. This work provides a framework within which to locate and define the time of appearance of alveolar progenitor cells during lung development, and raises important new questions about proximal and distal epithelial differentiation. The second group, led by Zena Werb, brings an extensive record of studying breast development and remodeling to the issues of lung development, with particular focus on the influence of the mesenchyme on epithelial progenitor cell (re)programming and the development of assays to visualize this process. The third group, led by the PI and colleagues, is creating lineage tracing reagents to facilitate the identification and isolation of alveolar epithelial progenitors, allow for the unambiguous interpretation of progenitor cell assays, and provide a means to explore the capacity of environmental cues, especially the extracellular matrix, to direct programming of adult type II cells toward multiple phenotypes. The major objectives of the project are to develop methods for the isolation and characterization of embryonic alveolar cell progenitors, compare the gene expression and developmental potential of these cells with adult type II cells, elucidate cues that reprogram adult type II cells with progenitor potential, and establish an in vivo transplantation assay to validate and screen for the capacity of progenitors to engage vascular elements and form alveolar tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
-
批准号:10702133
-
项目类别:
-
资助金额:$215.3万
-
财政年份:2022
-
负责人:Harold A Chapman
-
依托单位:
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
-
批准号:10418169
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2022
-
负责人:Harold A Chapman
-
依托单位:
Program to promote lung regeneration and block fibrosis
-
批准号:9893639
-
项目类别:
-
资助金额:$96.55万
-
财政年份:2020
-
负责人:Harold A Chapman
-
依托单位:
Program to promote lung regeneration and block fibrosis
-
批准号:10570862
-
项目类别:
-
资助金额:$96.88万
-
财政年份:2020
-
负责人:Harold A Chapman
-
依托单位:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
-
批准号:10181019
-
项目类别:
-
资助金额:$120.21万
-
财政年份:2016
-
负责人:Harold A Chapman
-
依托单位:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
-
批准号:10418711
-
项目类别:
-
资助金额:$118.64万
-
财政年份:2016
-
负责人:Harold A Chapman
-
依托单位:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
-
批准号:9355470
-
项目类别:
-
资助金额:$94.83万
-
财政年份:2016
-
负责人:Harold A Chapman
-
依托单位:
Epithelial Stem/Progenitor Cells in Repair of the Injured Lung
-
批准号:9109038
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2015
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:7318124
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:8079454
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:7623494
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:7458005
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:7816702
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:7430307
-
项目类别:
-
资助金额:$42.81万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:7630481
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:6619355
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:6896391
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:6752914
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:7009143
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:6319320
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
海外基金